In this episode of Gaining the Technology Leadership Edge, Mike Mahoney sits down with Nash Sichon, a technologist and startup founder whose company, SciSpot, was accepted into Y Combinator. Nash walks through what it actually takes to move from idea to execution when building a product in a highly complex and regulated space like life sciences.
Nash explains how SciSpot set out to reduce drug development timelines—typically 12 to 15 years—by automating research workflows. Early research suggested that 40–45% of these workflows could be automated, but customer discovery revealed a more immediate problem: data wasn’t even digitized or standardized. Some labs were still recording information on napkins. Referencing a Nature Journal finding that roughly 70% of life science research is not reproducible, Nash outlines why standardization became their first product focus.
The conversation covers Y Combinator’s emphasis on building the scrappiest possible MVP, validating willingness to pay, and doubling down on what actually works. Nash also shares leadership lessons from 14 years in tech, including why embracing change is non-negotiable, how leaders should empower engineers through constrained autonomy, and why not every shiny new technology deserves adoption. The episode closes with a balanced discussion on AI’s promise and its unresolved ethical and regulatory challenges.
